JAHA:正常的心血管功能可延缓老年人认知功能的减退

2016-03-17 QQduhp 译 MedSci原创

迈阿密大学米勒医学院Hannah Gardener博士及同事发现,相比心血管功能不佳的老人而言,心血管功能健康的老人出现认知能力下降的时间要延迟6年。研究结果发表在the American Heart Association。 随着年龄的增长,大脑的某些区域萎缩,导致民众认知能力不同程度出现减退,包括学习、记忆、组织和心理活动等。尽管我们无法阻止人类的衰老过程,但既往研究表明,健康的生活习惯如定期

迈阿密大学米勒医学院Hannah Gardener博士及同事发现,相比心血管功能不佳的老人而言,心血管功能健康的老人出现认知能力下降的时间要延迟6年。研究结果发表在Journal of the American Heart Association。 

随着年龄的增长,大脑的某些区域萎缩,导致民众认知能力不同程度出现减退,包括学习、记忆、组织和心理活动等。尽管我们无法阻止人类的衰老过程,但既往研究表明,健康的生活习惯如定期身体锻炼等有助于延缓认知功能减退。Gardener和同事通过研究发现,维护心血管功能健康也有助减缓民众认知功能减退。 

AHA公布的7项简单易行的心血管护理指南包括规律的身体锻炼、健康饮食、控制体重、避免吸烟和控制血糖、胆固醇和血压等。

研究人员对1033名平均年龄72岁且为曼哈顿北部地区研究参与者的老人进行了探究,其中16%是白人,19%是黑人,65%为拉美裔。
 
研究人员在研究开始时评估参与者7项护理指南的执行情况,并对他们的记忆、大脑思考和处理速度等进行了评估。研究人员在6年的随访时长内对722名参与者重复进行认知功能测试。

研究人员发现,研究初始时,心血管功能健康的老人大脑处理速度也较快,非吸烟者且血压和血糖正常的老人尤其如此。在随访中,研究人员发现,相比心血管功能不佳的老人而言,心血管功能健康的老人大脑处理速度和执行能力减退速度更慢。Gardener博士指出,执行AHA公布的7项心血管健康指南不仅可降低老人心脏病发作和卒中的风险,也降低其认知功能的减退速度。但他们表示仍需进行更进一步的研究,如高血压和高血糖等危险因素在老人认知功能减退进程中发挥的作用。

原始出处:

A healthy heart could protect against cognitive decline,MNT,16,Mar,2016

Hannah Gardener et al.Ideal cardiovascular health and cognitive aging in the Northern Manhattan Study, Journal of the American Heart Association, 16 Mar,2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=73731, encodeId=4aece37317b, content=机体都是相互联系的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Mar 25 09:22:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73026, encodeId=4fd5e3026de, content=学习了,很好,值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72674, encodeId=1aede2674be, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Tue Mar 22 13:05:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267292, encodeId=1246126e292cd, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511966, encodeId=2d05151196668, content=<a href='/topic/show?id=da82895e077' target=_blank style='color:#2F92EE;'>#血管功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89570, encryptionId=da82895e077, topicName=血管功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a8810427189, createdName=1249859em41(暂无昵称), createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-25 xingyong

    机体都是相互联系的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=73731, encodeId=4aece37317b, content=机体都是相互联系的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Mar 25 09:22:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73026, encodeId=4fd5e3026de, content=学习了,很好,值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72674, encodeId=1aede2674be, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Tue Mar 22 13:05:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267292, encodeId=1246126e292cd, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511966, encodeId=2d05151196668, content=<a href='/topic/show?id=da82895e077' target=_blank style='color:#2F92EE;'>#血管功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89570, encryptionId=da82895e077, topicName=血管功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a8810427189, createdName=1249859em41(暂无昵称), createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-23 dhzzm

    学习了,很好,值得

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=73731, encodeId=4aece37317b, content=机体都是相互联系的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Mar 25 09:22:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73026, encodeId=4fd5e3026de, content=学习了,很好,值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72674, encodeId=1aede2674be, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Tue Mar 22 13:05:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267292, encodeId=1246126e292cd, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511966, encodeId=2d05151196668, content=<a href='/topic/show?id=da82895e077' target=_blank style='color:#2F92EE;'>#血管功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89570, encryptionId=da82895e077, topicName=血管功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a8810427189, createdName=1249859em41(暂无昵称), createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-22 1de304d2m86(暂无匿称)

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=73731, encodeId=4aece37317b, content=机体都是相互联系的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Mar 25 09:22:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73026, encodeId=4fd5e3026de, content=学习了,很好,值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72674, encodeId=1aede2674be, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Tue Mar 22 13:05:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267292, encodeId=1246126e292cd, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511966, encodeId=2d05151196668, content=<a href='/topic/show?id=da82895e077' target=_blank style='color:#2F92EE;'>#血管功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89570, encryptionId=da82895e077, topicName=血管功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a8810427189, createdName=1249859em41(暂无昵称), createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-19 zhaohui6731
  5. [GetPortalCommentsPageByObjectIdResponse(id=73731, encodeId=4aece37317b, content=机体都是相互联系的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Mar 25 09:22:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73026, encodeId=4fd5e3026de, content=学习了,很好,值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:44:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72674, encodeId=1aede2674be, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Tue Mar 22 13:05:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267292, encodeId=1246126e292cd, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511966, encodeId=2d05151196668, content=<a href='/topic/show?id=da82895e077' target=_blank style='color:#2F92EE;'>#血管功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89570, encryptionId=da82895e077, topicName=血管功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a8810427189, createdName=1249859em41(暂无昵称), createdTime=Sat Mar 19 09:23:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

相关资讯

JAMA Dermatol:化脓性汗腺炎可增加全因死亡率和主要不良心血管事件的发生(附评论)

JAMA Dermatol:化脓性汗腺炎可增加全因死亡率和主要不良心血管事件的发生化脓性汗腺炎(HS)是一种常见的炎症性皮肤病。已知HS与心血管的(CV)危险因素有关,但是对于HS患者其CV疾病的发生风险尚未清楚。本研究旨在探究HS患者其CV疾病的发生风险。采用以人群为基础的队列研究,时间为1997年1月1日至2011年12月31日。在35368名丹麦人研究人群中,5964名HS患者年龄在18岁或

Am J Clin Nutr:钙摄入量与死亡间联系

研究者进行了一项大型的前瞻性队列研究,探究钙补充剂、膳食钙和总钙摄入与全因死亡、心血管疾病(CVD)相关死亡和癌症相关死亡率间的联系。该研究共纳入了132823名参与者,从1992/1993年随访到2012年。在1999和2003年获取了参与者膳食钙和钙补充剂的摄入情况。研究数据显示,在随访的17.5年时间里,发生了43186例死亡。对于男性,钙补充剂的摄入与死亡结局整体不相关(P-trend &

JAHA:打太极可帮助改善个体心血管系统的健康

图片来源:medicalxpress.com 近日,刊登在国际杂志Journal of the American Heart Association上的一项研究论文中,来自上海体育大学的研究人员通过研究发现,传统的中国运动比如太极或可帮助改善个体的健康以及心脏病、高血压及中风患者的健康情况。 研究者Yu Liu博士说道,传统的中国锻炼方式是一种低风险且极具潜力的干预措施,其可以有效帮助改

心血管急救用药大盘点

导  语: 相对于别的科室,心血管科每日硝烟弥漫,场面惊心动魄,医生如临大敌。 如冠心病出现胸闷、心慌气短、心律不齐、胸痛、胸骨后或心前区疼痛等。 心肌梗死时血压下降,大汗,四肢厥冷,均需急救处理。 因此,如何实现急救药物的规范化使用显得尤为关键。 对药理、用法、不良反应及注意事项等的熟练掌握,是临床医生在硝烟弥漫的临床战场抵抗劲敌(心血管疾病)的致胜法宝。

Cell Stem Cell:一种中间状态的心血管祖细胞可能成为心血管疾病钥匙

来自美国Gladstone研究所的研究人员能够制造一类处于胚胎干细胞和成体心脏细胞(adult heart cell)之间的细胞,这可能是治疗心脏病的关键。这些诱导性可增殖的心血管祖细胞(induced expandable cardiovascular progenitor cells, ieCPCs)是通过重编程小鼠皮肤中的成纤维细胞而产生的。它们可以有组织地发育成仍然能够复制的心脏细胞。当被